Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Permanyer
2022-07-01
|
| Sarja: | Gaceta Mexicana de Oncología |
| Aiheet: | |
| Linkit: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|